Our strategy – The Institute of Cancer Research, London
Our new five-year strategy aims to accelerate progress for cancer patients by harnessing the latest scientific knowledge and technology to drive innovation in treatment.
Our new five-year strategy aims to accelerate progress for cancer patients by harnessing the latest scientific knowledge and technology to drive innovation in treatment.
Prostate Cancer UK has today announced details of a £42 million screening trial, which aims to find the best way to screen men for prostate…
A new drug could offer a powerful way to sensitise tumours to immunotherapy, a new trial suggests.
Patients with aggressive, incurable cancers saw their tumours stop growing after they began taking a twice-a-day tablet.
Dr Stephen-John Sammut, a Clinician Scientist at The Institute of Cancer Research, London, and Honorary Consultant in Medical Oncology at The Royal Marsden NHS Foundation…
At the ICR, we are committed to improving the lives of cancer patients. Yet these discoveries take time and are only possible with continued support…
Combining two existing cancer drugs could offer promise for some children with an incurable childhood brain cancer, a new study suggests.
Scientists at The Institute of Cancer Research have helped discover and develop many targeted treatments that are enabling cancer patients to live longer and with…
It’s an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new…
Run the London Marathon for the Institute of Cancer Research and raise money for our life-saving research. Sign up today.
A Watford cancer survivor will take on the London Marathon this weekend in memory of two friends lost to the disease.